Angelo De Lauretis

Serum Interleukin 6 Is Predictive of Early Functional Decline and Mortality in Interstitial Lung Disease Associated with Systemic Sclerosis

Angelo De Lauretis, Piersante Sestini, Panagiotis Pantelidis et al. · The Journal of Rheumatology · 2013 · 257 citations · Full text

Rituximab in severe, treatment‐refractory interstitial lung disease

Gregory J. Keir, Toby M. Maher, Damien Ming et al. · Respirology · 2013 · 257 citations

Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial

Dina Visca, Letizia Mori, Vicky Tsipouri et al. · The Lancet Respiratory Medicine · 2018 · 215 citations · Full text

Quality Of Life, Advanced Lung Disease, Fibrotic Lung Disease +8

Predicting Outcomes in Idiopathic Pulmonary Fibrosis Using Automated Computed Tomographic Analysis

Joseph Jacob, Brian J. Bartholmai, Srinivasan Rajagopalan et al. · American Journal of Respiratory and Critical Care Medicine · 2018 · 194 citations · Full text

CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head and neck cancer

Stefania Boccia, Gabriella Cadoni, Fakhredin A. Sayed‐Tabatabaei et al. · Journal of Cancer Research and Clinical Oncology · 2007 · 97 citations · Full text

Neck Cancer, Cancer Risk, Medicine +11